Medicaid Drug pricing HeX-MAP

Last Updated on 11/13/2024

For all of the data viz purists out there, here’s another crack at the Medicaid Drug Pricing Heat Map that eliminates the pesky “Alaska Effect” (i.e. the annoyance that AK and HI distort the scale of a geographic map). We also simplified and streamlined the number of buttons and options on the Hex-Map to hopefully improve the efficiency of your Medicaid pricing distortion hunting activities.

NADAC Change Packed Bubble Chart

Last updated on 11/20/2024

Once a month (normally the 3rd or 4th week) CMS publishes the results of their monthly retail pharmacy survey.  The results of this survey reflect thousands of drug price changes. We wanted to be able to put some context around all of these changes, so we joined the survey results with Medicaid's latest dispensing data (Q1 2018) to better understand the aggregate impact of all of the latest generic pricing changes using a real life drug mix.    

Medicaid Markup Universe

Last updated on 08/02/2024

In traditional PBM “spread” contracts with payers, the payer pays one price for a generic claim, and the provider is paid some other amount for that claim. While calculating the precise spread in Medicaid is not possible given that PBM payments to pharmacies are not public, we can get a feel for how disconnected the price paid is from the ingredient cost by comparing CMS state utilization data to CMS NADAC data. From this comparison, we have derived “markup” and have created a celestial-feeling visualization for you to see where all of it is and is not.

Medicaid Markup Galaxies

Last updated on 08/02/2024

Looking to drill deeper into a state’s markup universe? Then this viz is for you. Medicaid Markup Galaxies separates each universe into three different groups (or celestially-speaking, “galaxies”). We call them the High-Cost, In-Range, and Low-Cost galaxies. The goal in doing so is to better quantify the nature of generic pricing distortions within state Medicaid programs.

Medicaid Drug Market Share Dashboard

Last updated on 02/14/2024

If we want to understand drug pricing, we need to understand supply and demand. And any study of supply and demand inevitably is going to lead to the hunt for market share data. Market share is an easy and convenient place to start to try to make sense of all of the generic drug pricing nonsense. Market share analysis shows lots of competitors, each with with a relatively small slice of the pie? That’s a signal of healthy competition among generic manufacturers, which should result in lower prices. Market share concentrated with one manufacturer? That’s not great for competition, and could explain pricing oddities for the drug. Our Medicaid Drug Market Share Dashboard is designed to help you answer these questions.

Brand Drug List Price Change Box Score

Last updated on 12/09/2024

Much like a box score in baseball tallies up each player’s stats for a game, our Brand Drug List Price Change Box Score tallies up all price changes by manufacturer and drug – for any period you want to see. The tool provides you with a decade of historical context, and for the first time (that we know of) weights price changes to better account for differences in utilization from one drug to another. Be careful though – the most significant limitation to this data is that it does not include manufacturer rebates. But the discussion on list price increases rages nonetheless – now at least you have better facts to contribute!

Medicare Part D Drug Pricing Ski Slope

Last Updated on 7/13/2019

Longing for winter, ski bums? Well, we have a big dump for you! In this viz, you can select a drug and view the price set for the drug by thousands of Part D plans. For good measure, we added a line to show you the true market-based cost of the drug, so you can see how frustratingly random pricing is across plans for generic drugs.

46brooklyn Drug Launch price contextualizer

Last Updated on 3/9/2023

You’ve seen the annual brand drug list price changes in our Brand Drug List Price Change Box Score, which can provide great insights on week-by-week drugmaker activity. But with heightened scrutiny and pressure on year-over-year list price increases, the launch prices of new drugs have become an increasingly important research space. But as is typical, much of vitriol over rising launch list prices is missing critical context and nuance, which we have set out to provide as best as possible. See for yourself in the new 46brooklyn Drug Launch Price Contextualizer.

Medicare Part D Drug Pricing Dashboard

Last updated on 5/1/2024

Explore total spending and per claim costs on thousands of drugs across Medicare Part D in 46brooklyn’s Medicare Part D Drug Pricing Dashboard. This dashboard takes Part D spending data published by CMS and adds helpful identifiers to gain better insight into Part D spending trends on brand, generic, and specialty drugs.

ABNORMAL DRUG PRICE INCREASE TRACKER (ADPIT)

Last updated on 11/14/2024

Generic drug prices are designed to go down. This, we all know. But many generic drug prices go up as well. Most times this is nothing to fret about, it’s just part of the random walk that is the price trend of all generic drugs. But other times, prices can increase quickly. It’s helpful to research these drugs to figure out what’s going on. But first we have to find them. If that’s what you’re looking to do, it’s time to call in some help from ADPIT!